Potentiation of catecholamine inhibition of ganglionic transmission by delta9-tetrahydrocannabinol.
D000818:Animals; D002395:Catecholamines / Q000494:pharmacology*; D004298:Dopamine / Q000494:pharmacology; D013759:Dronabinol / Q000494:pharmacology*; D004357:Drug Synergism; D004558:Electric Stimulation; D004837:Epinephrine / Q000494:pharmacology; D005071:Evoked Potentials / Q000187:drug effects; D005724:Ganglia / Q000187:drug effects*; D008297:Male; D009638:Norepinephrine / Q000494:pharmacology; D011817:Rabbits; D009435:Synaptic Transmission / Q000187:drug effects*; D013997:Time Factors
D002395:Catecholamines; D013759:Dronabinol; D004298:Dopamine; D009638:Norepinephrine; D004837:Epinephrine